Dan Cohen

Summary

Affiliation: Mental Health Services North-Holland North
Country: The Netherlands

Publications

  1. doi request reprint White blood cell monitoring during long-term clozapine treatment
    Dan Cohen
    Department of Severe Mental Illness, Mental Health Care Organization North Holland North, Heerhugowaard, The Netherlands
    Am J Psychiatry 170:366-9. 2013
  2. doi request reprint Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy
    Dan Cohen
    Department of Severe Mental Illness, Mental Health Care Organization North Holland North, Hectorlaan 19, 1702 CL Heerhugowaard, The Netherlands
    J Clin Psychiatry 73:1307-12. 2012
  3. ncbi request reprint [Clozapine screening: white bloodcell counts no longer sufficient]
    D Cohen
    Vakgroep KLinische Epidemiologie, Universitair Medisch Centrum Groningen, Heerhugowaard
    Tijdschr Psychiatr 52:785-90. 2010
  4. ncbi request reprint [Screening of adults with schizophrenia for metabolic complications caused by atypical antipsychotics]
    D Cohen
    Tijdschr Psychiatr 52:111-5. 2010
  5. ncbi request reprint Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment
    D Cohen
    Psychiatric Institute Rijngeest, Noordwijkerhout, The Netherlands
    Eur Neuropsychopharmacol 16:187-94. 2006
  6. ncbi request reprint Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders
    Dan Cohen
    Centre for Mental Health Care Rijngeestgroep, Noordwijkerhout, The Netherlands
    Diabetes Care 29:786-91. 2006
  7. ncbi request reprint Compulsory treatment with clozapine: a retrospective long-term cohort study
    Peter F J Schulte
    Department De Dijk, Mental Health Services North Holland North, Kennemerstraatweg 464, 1851 NG Heiloo, The Netherlands
    Int J Law Psychiatry 30:539-45. 2007
  8. ncbi request reprint Effect of risperidone on ghrelin and glucose in schizophrenia
    Dan Cohen
    Psychiatry Clin Neurosci 61:576. 2007
  9. ncbi request reprint Applicability of the oral glucose tolerance test in assessing prevalence and incidence of diabetes mellitus in schizophrenia
    Dan Cohen
    J Clin Psychiatry 68:1307-8; author reply 1308-9. 2007
  10. ncbi request reprint Atypical antipsychotic-induced diabetes mellitus in child and adolescent psychiatry
    Dan Cohen
    CNS Drugs 21:1035-8. 2007

Collaborators

  • C C Gispen-de Wied
  • J Peen
  • Ronald P Stolk
  • P F J Schulte
  • A Lernmark
  • Roos C Padmos
  • Roosmarijn C Drexhage
  • José A Spoelstra
  • Marjan A Versnel
  • Roel H DeRijk
  • Herbert Hooijkaas
  • Harm de Wit
  • Aart Jan van der Lely
  • Nico van Beveren
  • Esther M Knijff
  • Lynn Bekris
  • Hubertus G M Leufkens
  • Willem A Nolen
  • Joelle A Erkens
  • Diederick E Grobbee
  • Hemmo A Drexhage
  • Olav H Klungel
  • Ralph W Kupka
  • Henning Tiemeier

Detail Information

Publications16

  1. doi request reprint White blood cell monitoring during long-term clozapine treatment
    Dan Cohen
    Department of Severe Mental Illness, Mental Health Care Organization North Holland North, Heerhugowaard, The Netherlands
    Am J Psychiatry 170:366-9. 2013
    ..For mentally competent and adequately informed patients, the Netherlands Clozapine Collaboration Group now permits quarterly monitoring after the first 6 months of clozapine treatment...
  2. doi request reprint Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy
    Dan Cohen
    Department of Severe Mental Illness, Mental Health Care Organization North Holland North, Hectorlaan 19, 1702 CL Heerhugowaard, The Netherlands
    J Clin Psychiatry 73:1307-12. 2012
    ..The objective of this review is to determine whether an update of the screening guidelines for serious side effects with clozapine is evidence based...
  3. ncbi request reprint [Clozapine screening: white bloodcell counts no longer sufficient]
    D Cohen
    Vakgroep KLinische Epidemiologie, Universitair Medisch Centrum Groningen, Heerhugowaard
    Tijdschr Psychiatr 52:785-90. 2010
    ..The current situation is weighed up on the basis of a comparison of the chances that these side-effects can occur and cause death. The conclusion is that weekly or monthly screening should be carried out for all these side-effects...
  4. ncbi request reprint [Screening of adults with schizophrenia for metabolic complications caused by atypical antipsychotics]
    D Cohen
    Tijdschr Psychiatr 52:111-5. 2010
    ..Systematic screening, however, means that sideeffects can be diagnosed at an earlier, less severe stage, leading to higher rates of survival and remission. This should contribute to a normalising of the mortality rate...
  5. ncbi request reprint Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment
    D Cohen
    Psychiatric Institute Rijngeest, Noordwijkerhout, The Netherlands
    Eur Neuropsychopharmacol 16:187-94. 2006
    ....
  6. ncbi request reprint Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders
    Dan Cohen
    Centre for Mental Health Care Rijngeestgroep, Noordwijkerhout, The Netherlands
    Diabetes Care 29:786-91. 2006
    ..To address this issue, we decided to assess glucose metabolism in a population of patients with schizophrenia or schizoaffective disorder...
  7. ncbi request reprint Compulsory treatment with clozapine: a retrospective long-term cohort study
    Peter F J Schulte
    Department De Dijk, Mental Health Services North Holland North, Kennemerstraatweg 464, 1851 NG Heiloo, The Netherlands
    Int J Law Psychiatry 30:539-45. 2007
    ..Clozapine is the gold standard in treatment of treatment-resistant psychotic patients. We know little about the effects of compulsory treatment in patients unwilling to accept the necessary treatment...
  8. ncbi request reprint Effect of risperidone on ghrelin and glucose in schizophrenia
    Dan Cohen
    Psychiatry Clin Neurosci 61:576. 2007
  9. ncbi request reprint Applicability of the oral glucose tolerance test in assessing prevalence and incidence of diabetes mellitus in schizophrenia
    Dan Cohen
    J Clin Psychiatry 68:1307-8; author reply 1308-9. 2007
  10. ncbi request reprint Atypical antipsychotic-induced diabetes mellitus in child and adolescent psychiatry
    Dan Cohen
    CNS Drugs 21:1035-8. 2007
  11. doi request reprint Patients with schizophrenia show raised serum levels of the pro-inflammatory chemokine CCL2: association with the metabolic syndrome in patients?
    Roosmarijn C Drexhage
    Schizophr Res 102:352-5. 2008
  12. doi request reprint Scientific standards: critical comments on the pharmacoepidemiological study of second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia
    Dan Cohen
    J Clin Psychopharmacol 28:461-2; author reply 462-4. 2008
  13. ncbi request reprint Immunological characteristics of diabetes in schizophrenia
    Dan Cohen
    Diabetologia 48:1941-2. 2005
  14. ncbi request reprint Diabetes mellitus during olanzapine and quetiapine treatment in Japan
    Dan Cohen
    J Clin Psychiatry 66:265-6; author reply 266-7. 2005
  15. ncbi request reprint Antipsychotic drugs may worsen metabolic control in type 2 diabetes mellitus
    José A Spoelstra
    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
    J Clin Psychiatry 65:674-8. 2004
    ..In this study, we investigated whether the use of antipsychotic drugs in patients with diabetes leads to worsening of glycemic control...
  16. ncbi request reprint A high prevalence of organ-specific autoimmunity in patients with bipolar disorder
    Roos C Padmos
    Department of Immunology, Erasmus Medical Centre, Rotterdam, The Netherlands
    Biol Psychiatry 56:476-82. 2004
    ..Here we report the prevalence of other organ-specific autoantibodies: H/K adenosine triphosphatase (ATPA), glutamic acid decarboxylase-65 (GAD65A), and GAD-67 (GAD67A)...